封面
市場調查報告書
商品編碼
1705978

臨床營養市場:按營養類型、應用、年齡層、分銷管道和地區分類

Clinical Nutrition Market, By Nutrition Type, By Application, By Age Group, By Distribution Channel, By Geography

出版日期: | 出版商: Coherent Market Insights | 英文 180 Pages | 商品交期: 2-3個工作天內

價格
簡介目錄

2025 年全球臨床營養市場規模估計為 131.5 億美元,預計 2032 年將達到 197.7 億美元,2025 年至 2032 年的年複合成長率(CAGR)為 6.0%。

報告範圍 報告詳細資訊
基準年 2024 2025年的市場規模 131.5億美元
效能數據 2020-2024 預測期 2025-2032
預測期:2025-2032年複合年成長率: 6.00% 2032年價值預測 197.7億美元
數字。 2025年各地區臨床營養市場佔有率(%)
臨床營養市場-IMG1

臨床營養是指為急性病和營養不良患者或因特殊疾病需要改變日常飲食的患者提供專門的營養支持。這包括對患者營養需求的評估、診斷、介入和監測。臨床營養可以治療多種影響食物攝取和營養吸收的疾病,例如癌症、神經系統疾病、胃腸道疾病、傷口或損傷。它在減少疾病併發症、支持癒合過程以及改善患者的治療效果和復原時間方面發揮著至關重要的作用。由於全球慢性病的流行和老年人口的增加,過去十年對專業臨床營養的需求不斷增加。

市場動態:

全球臨床營養市場的成長受到老年人口的成長、慢性病和文明病的患病率的增加、居家照護和醫療保健環境中對營養產品的需求的增加以及嬰兒營養研發設施的推出等因素的推動。然而,臨床營養治療意識低下和嚴格的法律規範等因素正在限制市場的成長。基於個人基因圖譜的個人化營養產品的開發正在為市場相關人員創造機會。此外,在腫瘤學和神經病學等新治療領域中,腸內和腸外營養的應用研究日益增多,也預示著良好的前景。

例如,有機嬰兒奶粉公司 Bobbie Baby 於 10 月宣布正式推出Bobbie Labs,這是一個專注於嬰兒營養的研發中心。 Bobbi Labs 是該公司承諾在 2030 年投資 1 億美元擴大美國奶粉的取得、品質和選擇範圍的核心部分。

本研究的主要特點

  • 本報告對全球臨床營養市場進行了詳細分析,並以 2024 年為基準年,展示了預測期(2025-2032 年)的市場規模和複合年成長率。
  • 它揭示了各個領域的潛在收益成長機會,並解釋了該市場的有吸引力的投資提案矩陣。
  • 它還提供了有關市場促進因素、限制因素、機會、新產品發布和核准、市場趨勢、區域前景和主要企業採用的競爭策略的重要見解。
  • 全球臨床營養市場的主要企業根據以下參數進行分析,例如公司亮點、產品系列、主要亮點、財務表現和策略。
  • 研究涉及的主要企業包括雅培 (Abbott)、百特 (Baxter)、費森尤斯 (Fresenius SE &Co.KGaA)、Persanfarma、龍沙 (Lonza)、B. Braun SE、雀巢 (Nestle)、達能 (Danone SA)、百利高 (Perrigo Company plc)、Cestle)、達能 (Danone SA)、百利高 (Perrigo Company plc)、貝里夫集團 (RickSF) 和大良利集團時 (RBAgo Company plc)、大公素集團時(BASF ) 和大良利集團時 (RBAgo Company)、大公素集團(RwC) (Otsuka Pharmaceutical)。
  • 本報告的見解將使負責人和企業經營團隊能夠就未來的產品發布、新興趨勢、市場擴張和行銷策略做出明智的決策。
  • 全球臨床營養市場報告迎合了該行業的各個相關人員,包括投資者、供應商、產品製造商、經銷商、新進業者和金融分析師。
  • 相關人員可以透過用於分析全球臨床營養市場的各種策略矩陣來促進決策。

目錄:

第1章 調查目的與前提條件

  • 研究目標
  • 先決條件
  • 簡稱

第2章 市場展望

  • 報告描述
    • 市場定義和範圍
  • 執行摘要
  • Coherent Opportunity Map(COM)

第3章市場動態、法規與趨勢分析

  • 市場動態
  • 影響分析
  • 主要亮點
  • 監管情景
  • 產品發布/核准
  • PEST分析
  • 波特分析
  • 併購場景

4. 全球臨床營養市場-冠狀病毒(COVID-19)大流行的影響

  • COVID-19流行病學
  • 供需側分析
  • 經濟影響

5. 2020 年至 2032 年全球臨床營養市場(依營養類型分類)

  • 經腸營養
  • 經腸營養

6. 全球臨床營養市場(按應用),2020-2032

  • 癌症
  • 代謝紊亂
  • 胃腸道疾病
  • 神經系統疾病
  • 其他

7. 全球臨床營養市場(依年齡層分類),2020-2032 年

  • 成人
  • 孩子們
  • 老年人

8. 全球臨床營養市場(依分銷管道分類),2020-2032 年

  • 醫院藥房
  • 零售藥局
  • 網路藥局

9. 全球臨床營養市場(按地區分類),2020-2032 年

  • 北美洲
  • 歐洲
  • 亞太地區
  • 日本
  • 印度
  • ASEAN
  • 澳洲
  • 韓國
  • 其他亞太地區
  • 拉丁美洲
  • 中東
  • 非洲

第10章 競爭格局

  • Abbott
  • Baxter
  • Fresenius SE & Co. KGaA
  • Persanfarma
  • Lonza
  • B.Braun SE
  • Nestle
  • Danone SA
  • Perrigo Company plc
  • BASF SE
  • Reckitt Benckiser Group PLC.
  • Otsuka Pharmaceutical Co., Ltd

第 11 章 章節

  • 調查方法
  • 關於出版商
簡介目錄
Product Code: CMI980

Global Clinical Nutrition Market is estimated to be valued at USD 13.15 Bn in 2025 and is expected to reach USD 19.77 Bn by 2032, growing at a compound annual growth rate (CAGR) of 6.0% from 2025 to 2032.

Report Coverage Report Details
Base Year: 2024 Market Size in 2025: USD 13.15 Bn
Historical Data for: 2020 To 2024 Forecast Period: 2025 To 2032
Forecast Period 2025 to 2032 CAGR: 6.00% 2032 Value Projection: USD 19.77 Bn
Figure. Clinical Nutrition Market Share (%), By Region 2025
Clinical Nutrition Market - IMG1

Clinical nutrition refers to the specialized nutrition support provided to patients who are acutely ill and malnourished or have specific medical conditions requiring modifications to their usual diet. It involves the assessment, diagnosis, intervention, and monitoring of patients' nutritional needs. Clinical nutrition enables the management of various conditions like cancer, neurological disorders, gastrointestinal diseases, wounds, or injuries that impact dietary intake and nutrient absorption. It plays a vital role in reducing disease complications, supporting healing processes, and improving treatment outcomes and recovery times of patients. The widespread prevalence of chronic diseases and rising elderly population worldwide have increased the demand for specialized clinical nutrition over the past decade.

Market Dynamics:

The growth of the global clinical nutrition market is driven by the rising geriatric population, increasing prevalence of chronic and lifestyle diseases, growing demand for nutritional products in homecare and healthcare settings, and the launch of research and development facilities for infant nutrition. However, factors like limited awareness regarding clinical nutrition therapy and stringent regulatory framework are restraining the market growth. The development of personalized nutritional products based on an individual's genetic profile is paving opportunities for market players. Also, growing research on using enteral and parenteral nutrition in new therapeutic areas like oncology and neurology presents a lucrative outlook.

For instance, in October, Bobbie Baby, an organic infant formula company, announced the official launch of Bobbie Labs, its research and development hub, dedicated to infant feeding. Bobbie Labs is a core element of the company's commitment to invest US$ 100 million to increase infant formula access, quality, and options for all U.S. families by 2030.

Key Features of the Study:

  • This report provides an in-depth analysis of the global clinical nutrition market, and provides market size (US$ Bn) and Compound Annual Growth Rate (CAGR %) for the forecast period (2025-2032), considering 2024 as the base year
  • It elucidates potential revenue growth opportunities across different segments and explains attractive investment proposition matrices for this market
  • This study also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, market trends, regional outlook, and competitive strategies adopted by key players
  • It profiles key players in the global clinical nutrition market based on the following parameters such as company highlights, products portfolio, key highlights, financial performance, and strategies
  • The key companies covered as a part of this study include Abbott, Baxter, Fresenius SE & Co. KGaA, Persanfarma, Lonza, B. Braun SE, Nestle, Danone S.A., Perrigo Company plc, BASF SE, Reckitt Benckiser Group PLC., and Otsuka Pharmaceutical Co., Ltd.
  • Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
  • The global clinical nutrition market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
  • Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global clinical nutrition market

Detailed Segmentation:

  • By Nutrition Type:
    • Enteral Nutrition
    • Parenteral Nutrition
  • By Application:
    • Cancer
    • Metabolic Disorders
    • Gastrointestinal Disorders
    • Neurological Disorders
    • Others
  • By Age Group:
    • Adult
    • Pediatric
    • Geriatric
  • By Distribution Channel:
    • Hospital Pharmacies
    • Retail Pharmacies
    • Online Pharmacies
  • By Region:
    • North America
    • Europe
    • Asia Pacific
    • Latin America
    • Middle East
    • Africa
  • Company Profiles
    • Abbott
    • Baxter
    • Fresenius SE & Co. KGaA
    • Persanfarma
    • Lonza
    • B.Braun SE
    • Nestle
    • Danone S.A.
    • Perrigo Company plc
    • BASF SE
    • Reckitt Benckiser Group PLC.
    • Otsuka Pharmaceutical Co., Ltd

Table of Contents:

1. Research Objectives and Assumptions

  • Research Objectives
  • Assumptions
  • Abbreviations

2. Market Purview

  • Report Description
    • Market Definition and Scope
  • Executive Summary
    • Global Clinical Nutrition Market, By Nutrition Type
    • Global Clinical Nutrition Market, By Application
    • Global Clinical Nutrition Market, By Age Group
    • Global Clinical Nutrition Market, By Distribution Channel
    • Global Clinical Nutrition Market, By Region
  • Coherent Opportunity Map (COM)

3. Market Dynamics, Regulations, and Trends Analysis

  • Market Dynamics
    • Drivers
    • Restraints
    • Opportunities
  • Impact Analysis
  • Key Highlights
  • Regulatory Scenario
  • Product Launches/Approvals
  • PEST Analysis
  • PORTER's Analysis
  • Merger and Acquisition Scenario

4. Global Clinical Nutrition Market - Impact of Coronavirus (COVID-19) Pandemic

  • COVID-19 Epidemiology
  • Supply Side and Demand Side Analysis
  • Economic Impact

5. Global Clinical Nutrition Market, By Nutrition Type, 2020-2032, (US$ Bn)

  • Introduction
    • Market Share Analysis, 2025 and 2032 (%)
    • Y-o-Y Growth Analysis, 2021 - 2032
    • Segment Trends
  • Enteral Nutrition
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (US$ Bn)
  • Parenteral Nutrition
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (US$ Bn)

6. Global Clinical Nutrition Market, By Application, 2020-2032, (US$ Bn)

  • Introduction
    • Market Share Analysis, 2025 and 2032 (%)
    • Y-o-Y Growth Analysis, 2021 - 2032
    • Segment Trends
  • Cancer
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (US$ Bn)
  • Metabolic Disorders
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (US$ Bn)
  • Gastrointestinal Disorders
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (US$ Bn)
  • Neurological Disorders
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (US$ Bn)
  • Others
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (US$ Bn)

7. Global Clinical Nutrition Market, By Age Group, 2020-2032, (US$ Bn)

  • Introduction
    • Market Share Analysis, 2025 and 2032 (%)
    • Y-o-Y Growth Analysis, 2021 - 2032
    • Segment Trends
  • Adult
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (US$ Bn)
  • Pediatric
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (US$ Bn)
  • Geriatric
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (US$ Bn)

8. Global Clinical Nutrition Market, By Distribution Channel, 2020-2032, (US$ Bn)

  • Introduction
    • Market Share Analysis, 2025 and 2032 (%)
    • Y-o-Y Growth Analysis, 2021 - 2032
    • Segment Trends
  • Hospital Pharmacies
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (US$ Bn)
  • Retail Pharmacies
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (US$ Bn)
  • Online Pharmacies
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (US$ Bn)

9. Global Clinical Nutrition Market, By Region, 2020-2032, (US$ Bn)

  • Introduction
    • Market Share Analysis, 2025 and 2032 (%)
    • Y-o-Y Growth Analysis, 2021 - 2032
    • Segment Trends
  • North America
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Nutrition Type, 2020-2032, (US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Application, 2020-2032, (US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Age Group, 2020-2032, (US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2020-2032, (US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Country, 2020-2032, (US$ Bn)
      • U.S.
      • Canada
  • Europe
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Nutrition Type, 2020-2032, (US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Application, 2020-2032, (US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Age Group, 2020-2032, (US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2020-2032, (US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Country, 2020-2032, (US$ Bn)
      • U.K.
      • Germany
      • Italy
      • France
      • Spain
      • Russia
      • Rest of Europe
  • Asia Pacific
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Nutrition Type, 2020-2032, (US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Application, 2020-2032, (US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Age Group, 2020-2032, (US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2020-2032, (US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Country, 2020-2032, (US$ Bn)
    • China
  • Japan
  • India
  • ASEAN
  • Australia
  • South Korea
  • Rest of Asia Pacific
  • Latin America
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Nutrition Type, 2020-2032, (US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Application, 2020-2032, (US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Age Group, 2020-2032, (US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2020-2032, (US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Country, 2020-2032, (US$ Bn)
      • Brazil
      • Mexico
      • Argentina
      • Rest of Latin America
  • Middle East
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Nutrition Type, 2020-2032, (US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Application, 2020-2032, (US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Age Group, 2020-2032, (US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2020-2032, (US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Country, 2020-2032, (US$ Bn)
      • GCC
      • Israel
      • Rest of Middle East
  • Africa
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Nutrition Type, 2020-2032, (US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Application, 2020-2032, (US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Age Group, 2020-2032, (US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2020-2032, (US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Country/Region, 2020-2032, (US$ Bn)
      • North Africa
      • Central Africa
      • South Africa

10. Competitive Landscape

  • Abbott
    • Company Highlights
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • Baxter
    • Company Highlights
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • Fresenius SE & Co. KGaA
    • Company Highlights
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • Persanfarma
    • Company Highlights
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • Lonza
  • B.Braun SE
  • Nestle
  • Danone S.A.
  • Perrigo Company plc
  • BASF SE
  • Reckitt Benckiser Group PLC.
  • Otsuka Pharmaceutical Co., Ltd

11. Section

  • Research Methodology
  • About us